查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575502

肾上腺素市场：按类型、应用、最终用户、剂型、通路、年龄层、给药途径- 2025-2030 年全球预测

Epinephrine Market by Type (Inhalation, Injectable, Oral), Application (Anaphylaxis, Asthma Attacks, Cardiac Arrest), End-User, Dosage Form, Distribution Channel, Age Group, Route of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肾上腺素市值为19.9亿美元，预计2024年将达到21.9亿美元，复合年增长率为10.37%，预计到2030年将达到39.8亿美元。

肾上腺素是治疗严重过敏反应（过敏反应）、气喘、心臟麻痹的重要药物，在製药和医疗领域有着广泛的用途。需要它是因为它具有挽救生命的特性，作为一种快速反应治疗方法，可以透过收缩血管和放鬆气道肌肉来对抗严重的过敏反应。肾上腺素的用途主要用于紧急医疗环境，通常使用Epipen等自动注射器进行注射，但也可以由医疗保健专业人员透过注射进行注射。最终用途范围从医院、诊所到被诊断患有严重过敏或有过敏反应风险的人的居家照护。

主要市场统计
基准年[2023] 19.9亿美元
预测年份 [2024] 21.9亿美元
预测年份 [2030] 39.8亿美元
复合年增长率（%） 10.37%

肾上腺素市场的成长受到全球过敏率上升、公众对过敏反应的认识以及政府强制在学校和公共设施中储备肾上腺素自动注射器的卫生倡议的显着影响。这个市场开拓的机会包括开发具有成本效益的自动注射器、输送机制的进步以及更广泛的市场渗透，特别是在目前准入有限的新兴市场。公司可以专注于研发以降低製造成本或开发更易于使用且技术整合度更高的设备以增加市场占有率。

然而，该市场面临一些限制，例如当前产品的高成本、监管挑战以及学名药和替代疗法的竞争压力。此外，供应链中断和消费者因难以负担的价格而犹豫不决也是挑战。创新的关键领域包括开发非专利且负担得起的肾上腺素製剂、厌恶针头患者的替代品、延长保质期的非冷藏储存选择，以及提醒用户正确剂量的数字解决方案以进行鼓励和教育。

肾上腺素市场的性质是动态的，需求根据过敏流行率和紧急运输率而波动。相关人员将重点关注与医疗保健提供者的策略伙伴关係和教育宣传活动，以提高意识，同时加强市场准入，以确保促进强大的市场占有率和成长。

市场动态：揭示快速发展的肾上腺素市场的关键市场洞察

供需的动态交互作用正在改变肾上腺素市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 过敏和过敏反应盛行率上升，需要紧急服用肾上腺素
    • 提高大众对肾上腺素在过敏性紧急情况下重要性的认识和教育
    • 肾上腺素自动注射器技术的进步提高了使用者的便利性和可靠性
    • 支持政府政策和倡议，以提高肾上腺素自动注射器的可用性和可负担性
  • 市场限制因素
    • 供应链中断或原料短缺可能会影响肾上腺素产品的供应。
    • 来自替代疗法和学名药的激烈竞争可能会影响市场占有率
  • 市场机会
    • 对儿科肾上腺素自动注射器的需求不断增长，以确保剂量准确且易于使用
    • 医疗保健提供者加强了宣传宣传活动，强调获得肾上腺素的重要性
    • 肾上腺素给药装置的技术进步可改善患者的治疗效果和依从性
  • 市场挑战
    • 在全球经济不稳定的情况下应对肾上腺素市场生产成本上升
    • 解决肾上腺素生产所需的原料短缺及其对市场的影响

波特五力：驾驭肾上腺素市场的策略工具

波特的五力框架是了解肾上腺素市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肾上腺素市场的外部影响

外部宏观环境因素在塑造肾上腺素市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解肾上腺素市场的竞争格局

肾上腺素市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵肾上腺素市场供应商的绩效评估

FPNV定位矩阵是评估肾上腺素市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製您在肾上腺素市场的成功之路

肾上腺素市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 需要紧急管理的过敏和过敏反应发生率增加
      • 提高大众对肾上腺素在过敏性紧急情况下重要性的认识和教育
      • 自动注射器技术的进步提高了使用者的便利性和可靠性
      • 支持政府政策和倡议，以提高肾上腺素自动注射器的可近性和可负担性
    • 抑制因素
      • 供应链中断或原材料短缺可能会影响市场上肾上腺素产品的供应。
      • 来自替代疗法和学名药的竞争加剧可能会影响市场占有率
    • 机会
      • 对剂量准确且易于使用的儿科自动注射器的需求正在增加。
      • 医疗保健提供者进行更多宣传宣传活动，强调获取肾上腺素的重要性
      • 肾上腺素输送装置的技术进步改善了患者的治疗效果和依从性
    • 任务
      • 在全球经济不确定性的情况下管理肾上腺素市场不断上升的生产成本
      • 解决肾上腺素生产必需原料短缺及其对市场的影响
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章肾上腺素市场：依类型

  • 吸入
  • 可注射的
    • 肾上腺素自动注射器
    • 预填充式注射器
  • 口服

第七章 肾上腺素市场：依应用分类

  • 过敏反应
  • 气喘发作
  • 心臟麻痹
  • 表浅出血

第 8 章 肾上腺素市场：依最终使用者分类

  • 门诊手术中心
  • 诊所
  • 家庭护理设置
  • 医院

第九章按剂型分類的肾上腺素市场

  • 气体
  • 液体
  • 固体的

第10章肾上腺素市场：按分销管道

  • 医院药房
  • 网路药房
  • 零售药房

第十一章肾上腺素市场：依年龄组

  • 成人
  • 小儿科

第十二章肾上腺素市场：依给药途径

  • 肌肉注射
  • 静脉
  • 皮下的

第十三章美洲肾上腺素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十四章亚太肾上腺素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十五章欧洲、中东和非洲肾上腺素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0108

The Epinephrine Market was valued at USD 1.99 billion in 2023, expected to reach USD 2.19 billion in 2024, and is projected to grow at a CAGR of 10.37%, to USD 3.98 billion by 2030.

Epinephrine, a critical medication for treating severe allergic reactions (anaphylaxis), asthma, and cardiac arrest, has a broad scope within the pharmaceutical and medical sectors. Its necessity stems from its life-saving properties as a rapid response treatment that counters severe allergic responses by constricting blood vessels and relaxing airway muscles. The application of epinephrine is mainly seen in emergency medical settings, often delivered via auto-injectors like EpiPens, though it can also be administered through injections by healthcare professionals. The end-use scope spans hospitals, clinics, and home care for individuals with diagnosed severe allergies or at risk of anaphylaxis.

KEY MARKET STATISTICS
Base Year [2023] USD 1.99 billion
Estimated Year [2024] USD 2.19 billion
Forecast Year [2030] USD 3.98 billion
CAGR (%) 10.37%

The epinephrine market growth is significantly influenced by the rising incidence of allergies worldwide, increasing public awareness about anaphylaxis, and governmental health initiatives that require schools and public places to stock epinephrine auto-injectors. Opportunities within this market include the development of cost-effective auto-injectors, advancements in delivery mechanisms, and broader geographic market penetration, especially in developing regions where access is currently limited. Companies can focus on R&D to reduce production costs or create more user-friendly and technology-integrated devices for enhanced market share.

However, the market faces limitations such as high costs of current epinephrine products, regulatory challenges, and competitive pressures from generic versions and alternative therapies. Supply chain disruptions and consumer hesitation based on affordability also pose challenges. Key areas for innovation include the development of generic, affordable epinephrine formulations, alternatives for needle-phobic patients, non-refrigerated storage options to extend shelf life, and digital solutions to remind and educate users about proper administration.

The nature of the epinephrine market is dynamic, with fluctuating demand dependent on allergy prevalence and emergency rates. Stakeholders should focus on strategic partnerships with healthcare providers and educational campaigns to promote awareness while enhancing access to ensure robust market presence and drive growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Epinephrine Market

The Epinephrine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of allergies and anaphylaxis incidents necessitating emergency epinephrine administration
    • Increased public awareness and education on the importance of epinephrine in anaphylactic emergencies
    • Advancements in epinephrine auto-injector technology enhancing user convenience and reliability
    • Supportive government policies and initiatives promoting the accessibility and affordability of epinephrine auto-injectors
  • Market Restraints
    • Supply chain disruptions and raw material shortages can impact the availability of epinephrine products in the market
    • Increasing competition from alternative therapies and generic drugs may affect the market share
  • Market Opportunities
    • Rising demand for pediatric epinephrine auto-injectors designed for precise dosing and ease of use
    • Growth in awareness campaigns by healthcare providers highlighting the importance of epinephrine access
    • Technological advancements in epinephrine delivery devices for improved patient outcomes and compliance
  • Market Challenges
    • Managing the rising costs of production in the epinephrine market amidst global economic uncertainties
    • Addressing the scarcity of raw materials crucial for epinephrine production and its market implications

Porter's Five Forces: A Strategic Tool for Navigating the Epinephrine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Epinephrine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Epinephrine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Epinephrine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Epinephrine Market

A detailed market share analysis in the Epinephrine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Epinephrine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Epinephrine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Epinephrine Market

A strategic analysis of the Epinephrine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Epinephrine Market, highlighting leading vendors and their innovative profiles. These include Adamis Pharmaceuticals Corporation, Amphastar Pharmaceuticals, Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Cipla Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Hikma Pharmaceuticals plc, Hospira, Inc., Impax Laboratories, Inc., Kaleo Inc., Meridian Medical Technologies, Inc., Mylan N.V., Mylan N.V.2, Novartis International AG, Pfizer Inc., Sandoz International GmbH, Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Epinephrine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Inhalation, Injectable, and Oral. The Injectable is further studied across Epinephrine Auto-Injector and Prefilled Syringes.
  • Based on Application, market is studied across Anaphylaxis, Asthma Attacks, Cardiac Arrest, and Superficial Bleeding.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, Homecare Settings, and Hospitals.
  • Based on Dosage Form, market is studied across Gas, Liquid, and Solid.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Age Group, market is studied across Adults and Pediatrics.
  • Based on Route of Administration, market is studied across Intramuscular, Intravenous, and Subcutaneous.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of allergies and anaphylaxis incidents necessitating emergency epinephrine administration
      • 5.1.1.2. Increased public awareness and education on the importance of epinephrine in anaphylactic emergencies
      • 5.1.1.3. Advancements in epinephrine auto-injector technology enhancing user convenience and reliability
      • 5.1.1.4. Supportive government policies and initiatives promoting the accessibility and affordability of epinephrine auto-injectors
    • 5.1.2. Restraints
      • 5.1.2.1. Supply chain disruptions and raw material shortages can impact the availability of epinephrine products in the market
      • 5.1.2.2. Increasing competition from alternative therapies and generic drugs may affect the market share
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for pediatric epinephrine auto-injectors designed for precise dosing and ease of use
      • 5.1.3.2. Growth in awareness campaigns by healthcare providers highlighting the importance of epinephrine access
      • 5.1.3.3. Technological advancements in epinephrine delivery devices for improved patient outcomes and compliance
    • 5.1.4. Challenges
      • 5.1.4.1. Managing the rising costs of production in the epinephrine market amidst global economic uncertainties
      • 5.1.4.2. Addressing the scarcity of raw materials crucial for epinephrine production and its market implications
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Epinephrine Market, by Type

  • 6.1. Introduction
  • 6.2. Inhalation
  • 6.3. Injectable
    • 6.3.1. Epinephrine Auto-Injector
    • 6.3.2. Prefilled Syringes
  • 6.4. Oral

7. Epinephrine Market, by Application

  • 7.1. Introduction
  • 7.2. Anaphylaxis
  • 7.3. Asthma Attacks
  • 7.4. Cardiac Arrest
  • 7.5. Superficial Bleeding

8. Epinephrine Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Homecare Settings
  • 8.5. Hospitals

9. Epinephrine Market, by Dosage Form

  • 9.1. Introduction
  • 9.2. Gas
  • 9.3. Liquid
  • 9.4. Solid

10. Epinephrine Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies

11. Epinephrine Market, by Age Group

  • 11.1. Introduction
  • 11.2. Adults
  • 11.3. Pediatrics

12. Epinephrine Market, by Route of Administration

  • 12.1. Introduction
  • 12.2. Intramuscular
  • 12.3. Intravenous
  • 12.4. Subcutaneous

13. Americas Epinephrine Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Epinephrine Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Epinephrine Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adamis Pharmaceuticals Corporation
  • 2. Amphastar Pharmaceuticals, Inc.
  • 3. AstraZeneca plc
  • 4. Boehringer Ingelheim GmbH
  • 5. Cipla Limited
  • 6. Dr. Reddy's Laboratories Ltd.
  • 7. GlaxoSmithKline plc
  • 8. Hikma Pharmaceuticals plc
  • 9. Hospira, Inc.
  • 10. Impax Laboratories, Inc.
  • 11. Kaleo Inc.
  • 12. Meridian Medical Technologies, Inc.
  • 13. Mylan N.V.
  • 14. Mylan N.V.2
  • 15. Novartis International AG
  • 16. Pfizer Inc.
  • 17. Sandoz International GmbH
  • 18. Sanofi S.A.
  • 19. Sun Pharmaceutical Industries Ltd.
  • 20. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. EPINEPHRINE MARKET RESEARCH PROCESS
  • FIGURE 2. EPINEPHRINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPINEPHRINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPINEPHRINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPINEPHRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPINEPHRINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPINEPHRINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPINEPHRINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPINEPHRINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EPINEPHRINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EPINEPHRINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS EPINEPHRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS EPINEPHRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES EPINEPHRINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES EPINEPHRINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. EPINEPHRINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. EPINEPHRINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPINEPHRINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPINEPHRINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPINEPHRINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPINEPHRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPINEPHRINE MARKET DYNAMICS
  • TABLE 7. GLOBAL EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPINEPHRINE MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPINEPHRINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPINEPHRINE MARKET SIZE, BY EPINEPHRINE AUTO-INJECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPINEPHRINE MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPINEPHRINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPINEPHRINE MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EPINEPHRINE MARKET SIZE, BY ASTHMA ATTACKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPINEPHRINE MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EPINEPHRINE MARKET SIZE, BY SUPERFICIAL BLEEDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EPINEPHRINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPINEPHRINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EPINEPHRINE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EPINEPHRINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EPINEPHRINE MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EPINEPHRINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EPINEPHRINE MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL EPINEPHRINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL EPINEPHRINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL EPINEPHRINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL EPINEPHRINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL EPINEPHRINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL EPINEPHRINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL EPINEPHRINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL EPINEPHRINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS EPINEPHRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES EPINEPHRINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC EPINEPHRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 331. SWEDEN EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 347. TURKEY EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 348. TURKEY EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 349. TURKEY EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 363. UNITED KINGDOM EPINEPHRINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 364. UNITED KINGDOM EPINEPHRINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 365. UNITED KINGDOM EPINEPHRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 366. UNITED KINGDOM EPINEPHRINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 367. UNITED KINGDOM EPINEPHRINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 368. UNITED KINGDOM EPINEPHRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 369. UNITED KINGDOM EPINEPHRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 370. UNITED KINGDOM EPINEPHRINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 371. EPINEPHRINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 372. EPINEPHRINE MARKET, FPNV POSITIONING MATRIX, 2023